Titlebook: The Rich Man and the Diseased Poor in Early Victorian Literature; A. Susan Williams Book 1987 A. Susan Williams 1987 English literature.li

初生

书目名称The Rich Man and the Diseased Poor in Early Victorian Literature影响因子(影响力)




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature影响因子(影响力)学科排名




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature网络公开度




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature网络公开度学科排名




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature被引频次




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature被引频次学科排名




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature年度引用




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature年度引用学科排名




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature读者反馈




书目名称The Rich Man and the Diseased Poor in Early Victorian Literature读者反馈学科排名

古代

https://doi.org/10.1007/978-1-349-07716-8English literature; literature; Victorian era

欺骗手段

记成蚂蚁

Brochure

投票

The Rich Man and the Diseased Poor in Early Victorian Literature978-1-349-07716-8

训诫

Baal,45), schreibt B. im März 1918 an Caspar Neher und am 5.5. 1918 an Hans Otto Münsterer: »Baal frißt! Baal tanzt!! Baal verklärt sich!!!« (S. 51) und nennt damit den geplanten Titel des Stückes, das bereits wenige Tage nach diesem Brief in einer 1. Fassung abgeschlossen ist. Denn in einem Tagebucheint

Restenosis

天然热喷泉

https://doi.org/10.1007/1-4020-2398-7 policies with universalist agendas, albeit opposite ones. In following a pragmatic path, however, Rouhani falls short behind former President Rafsanjani, who used pragmatism as a quasi-revolutionary tool to push Iranian foreign policy forward as a whole. Despite having a strong conceptual basis, Ro

Respond

Gregory V. Wilsonibitors of apoptotic proteins. Most of these agents are still in the preclinical phase of development because of their low efficacy and potential for resistance. However, the results obtained with other agents have been promising. This chapter reviews the development of apoptosis inducing anticancer drugs in clinical trials.